Brokerages expect Owens & Minor, Inc. (NYSE:OMI) to announce $2.49 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Owens & Minor’s earnings, with the highest sales estimate coming in at $2.52 billion and the lowest estimate coming in at $2.47 billion. Owens & Minor posted sales of $2.54 billion during the same quarter last year, which would indicate a negative year-over-year growth rate of 2%. The firm is expected to announce its next earnings report on Tuesday, February 18th.

According to Zacks, analysts expect that Owens & Minor will report full year sales of $9.84 billion for the current financial year, with estimates ranging from $9.81 billion to $9.86 billion. For the next year, analysts expect that the company will post sales of $9.83 billion, with estimates ranging from $9.76 billion to $9.91 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Owens & Minor.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.20 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.01. Owens & Minor had a negative net margin of 2.88% and a positive return on equity of 4.89%. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.45 billion. During the same quarter last year, the business earned $0.32 earnings per share. Owens & Minor’s quarterly revenue was down 2.7% compared to the same quarter last year.

OMI has been the topic of several recent analyst reports. ValuEngine raised shares of Owens & Minor from a “hold” rating to a “buy” rating in a research note on Tuesday, October 1st. Zacks Investment Research downgraded shares of Owens & Minor from a “strong-buy” rating to a “hold” rating in a research note on Saturday. Finally, Bank of America increased their target price on shares of Owens & Minor from $4.00 to $7.50 and gave the company a “neutral” rating in a research note on Friday, September 6th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. Owens & Minor presently has an average rating of “Hold” and a consensus price target of $6.90.

Shares of OMI traded down $0.12 during midday trading on Friday, hitting $6.71. The stock had a trading volume of 1,539,535 shares, compared to its average volume of 1,588,189. Owens & Minor has a 1 year low of $2.43 and a 1 year high of $9.33. The firm has a market cap of $453.79 million, a PE ratio of 5.83 and a beta of 1.45. The company has a debt-to-equity ratio of 3.57, a current ratio of 1.74 and a quick ratio of 0.85. The stock’s 50 day moving average is $6.51 and its 200 day moving average is $4.51.

Institutional investors and hedge funds have recently made changes to their positions in the company. Bank of Montreal Can raised its stake in shares of Owens & Minor by 66.9% in the second quarter. Bank of Montreal Can now owns 8,066 shares of the company’s stock valued at $26,000 after acquiring an additional 3,233 shares during the period. Atlantic Union Bankshares Corp purchased a new position in Owens & Minor in the 2nd quarter worth about $36,000. Stone Ridge Asset Management LLC purchased a new position in Owens & Minor in the 2nd quarter worth about $50,000. Royal Bank of Canada increased its stake in Owens & Minor by 37.4% in the 2nd quarter. Royal Bank of Canada now owns 17,241 shares of the company’s stock worth $55,000 after buying an additional 4,689 shares during the period. Finally, First Trust Advisors LP purchased a new position in Owens & Minor in the 1st quarter worth about $56,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

See Also: Back-End Load

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with's FREE daily email newsletter.